
Over 5 million Americans could benefit if the U.S. Food and Drug Administration approves the “magic mushroom” psychedelic psilocybin as a treatment for depression, researchers estimate. “While our analysis is a crucial first step, we’ve only scratched the surface in understanding the true public health impact psilocybin therapy may have,” said study co-author Dr. Charles Raison.… read on > read on >